CIBOsp. z o.o.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2005-01-25
Share capital
100,000.00 PLN
Registered address
Osiedle Parkowe 14/1, 32-083 Balice, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 271 days for 2021).

  • 2025not filed
  • 202411/07/2025
  • 202314/02/2025
  • 202212/04/2023
  • 202112/04/2023
  • 202006/05/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Industry · Wholesale of pharmaceutical goods1,122 / 1,550
Top 72%
Division · Wholesale trade19,807 / 28,995
Top 68%
Voivodeship · Małopolskie24,151 / 46,033
Top 52%
Country · Poland263,742 / 495,850
Top 53%

Results vs industry

Revenue
This companyUSD 141.50kMedianUSD 1.07mAverageUSD 22.38m
Net profit
This companyUSD 2.55kMedianUSD 37.33kAverageUSD 879.18k
Operating costs
This companyUSD 134.97kMedianUSD 926.31kAverageUSD 21.06m
Assets
This companyUSD 221.55kMedianUSD 609.81kAverageUSD 11.84m

Authorized Representatives

Jakub Smorąg – President of the Management Board

Manner of representation

Each member of the management board independently or the commercial proxy independently is authorized to represent the company and make declarations of will.

Ownership

OwnerSharesShare valueStake
Barbara Renata Smorągage 53
100$13,506.2150%
Maria Smorągage 27
100$13,506.2150%

Barbara Renata Smorąg and Maria Smorąg hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Subsidiaries

NameStake
Stemcosp. z o.o.
50%

Bank accounts

Registered as a VAT taxpayer on 1997-01-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

7 public aid cases recorded, with a total value of $19,811.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$983
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$12,308
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$983

Competitors

Name
Bardomedsp. z o.o.
Medimessp. z o.o.
Optimed Pro-Office Cirrosp. j.
Model MedicalS.A.
Interforum Pharmasp. z o.o.
Softmedicasp. z o.o.
Toto Pharma Polandsp. z o.o.
Medyczniesp. z o.o.
Eduaidsp. z o.o.
Beyond Medical Aesthetics Polskasp. z o.o.

Change history

DateEvent
2011-08-31Share capital increase
2011-08-31Switch to PKD 2007
2006-12-19Share capital increase
2005-01-25Entered in the register

FAQ

Last updated: 2026-04-11